Haploidentical haematopoietic stem cell transplantation using CD3 or CD3/CD19 depletion and conditioning with fludarabine, cyclophosphamide and antithymocyte globulin for acquired severe aplastic anaemia

Br J Haematol. 2012 Apr;157(1):139-42. doi: 10.1111/j.1365-2141.2011.08924.x. Epub 2011 Nov 5.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Anemia, Aplastic / mortality
  • Anemia, Aplastic / therapy*
  • Antigens, CD19*
  • Antilymphocyte Serum / administration & dosage*
  • Antineoplastic Agents / administration & dosage*
  • CD3 Complex*
  • Cyclophosphamide / administration & dosage*
  • Female
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Immunologic Factors / administration & dosage*
  • Lymphocyte Depletion*
  • Male
  • Myeloablative Agonists / administration & dosage*
  • Prospective Studies
  • Severity of Illness Index
  • Transplantation Conditioning*
  • Transplantation, Homologous
  • Unrelated Donors*
  • Vidarabine / administration & dosage
  • Vidarabine / analogs & derivatives*

Substances

  • Antigens, CD19
  • Antilymphocyte Serum
  • Antineoplastic Agents
  • CD3 Complex
  • Immunologic Factors
  • Myeloablative Agonists
  • Cyclophosphamide
  • Vidarabine
  • fludarabine